 |
| Ray Jordan |
Ray Jordan, who held top PR jobs at Amgen, Johnson & Johnson and Pfizer, has joined biotech firm Moderna, which has developed the first US COVID-19 vaccine to post positive trial results.
He will take the chief corporate affairs officer slot.
Jordan was previously senior VP, corporate affairs at Amgen, where he was responsible for all internal and external communications, issues management and philanthropy. Prior to joining Amgen, he was VP of public affairs and corporate communication for Johnson & Johnson, and has also served as VP of communications and information at Pfizer.
“His strategic communications and management experience at global commercial biopharmaceutical companies will be a tremendous asset as we continue into late-stage commercial development of our COVID-19 vaccine and our CMV vaccine,” said Moderna chief executive officer Stéphane Bancel.
Moderna has strategic alliances with Merck, AstraZeneca, Pentagon's Defense Advanced Research Projects Agency and Biomedical Advanced Research and Development Authority, which is part of the Dept. of Health and Human Services.
Israel is in advanced discussions with Moderna to buy its vaccine, which will begin a test trial of 30,000 volunteers next month.
Healing the Sick Care System: Why People Matter, a new book from FINN Partners chair global health and purpose Gil Bashe, says that the current healthcare system is not broken because it lacks innovation, talent or investment, but because it has lost sight of the people it exists to serve.
Jeff Smokler, former president at healthcare specialist imre, joins Washington-based Avoq to head its PA practice.
Supreme Group, healthcare marketing and communications platform, has merged its Amendola Communications (Fountain Hills, AZ) and Health+Commerce (Newport Beach, CA) units to form Supreme Communications, a full-service PR shop, under Ketchum alum Nicky Battle.
Even as technology changes the rules of engagement, digital health brands still control the most powerful tool they have—their story.
